ZA982818B - Prevention of breast cancer using selective estrogen receptor modulators. - Google Patents
Prevention of breast cancer using selective estrogen receptor modulators.Info
- Publication number
- ZA982818B ZA982818B ZA9802818A ZA982818A ZA982818B ZA 982818 B ZA982818 B ZA 982818B ZA 9802818 A ZA9802818 A ZA 9802818A ZA 982818 A ZA982818 A ZA 982818A ZA 982818 B ZA982818 B ZA 982818B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- breast cancer
- estrogen receptor
- receptor modulators
- selective estrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4311897P | 1997-04-09 | 1997-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA982818B true ZA982818B (en) | 1999-10-04 |
Family
ID=21925594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9802818A ZA982818B (en) | 1997-04-09 | 1998-04-02 | Prevention of breast cancer using selective estrogen receptor modulators. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0975628A4 (xx) |
JP (1) | JP2001518897A (xx) |
KR (1) | KR20010006215A (xx) |
CN (1) | CN1259945A (xx) |
AU (1) | AU6957398A (xx) |
CA (1) | CA2286207A1 (xx) |
EA (1) | EA199900910A1 (xx) |
HU (1) | HUP0001845A2 (xx) |
ID (1) | ID23653A (xx) |
IL (1) | IL132279A0 (xx) |
NO (1) | NO994902L (xx) |
PL (1) | PL336206A1 (xx) |
TR (1) | TR199903244T2 (xx) |
WO (1) | WO1998045286A1 (xx) |
ZA (1) | ZA982818B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
EA022760B1 (ru) | 2007-10-16 | 2016-02-29 | Репрос Терапьютикс Инк. | Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин |
AU2013225869B2 (en) | 2012-02-29 | 2017-06-08 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
MA38325B1 (fr) | 2013-02-19 | 2019-03-29 | Novartis Ag | Dérivés de benzothiophène et compositions correspondantes en tant qu'agents de dégradation sélectifs des récepteurs des œstrogènes |
GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
JP7048505B2 (ja) | 2015-11-10 | 2022-04-05 | パラクリン セラピューティクス エービー | Pdgf-cc阻害剤および抗エストロゲン剤によるer陰性乳癌の処置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3989569B2 (ja) * | 1995-02-28 | 2007-10-10 | イーライ リリー アンド カンパニー | ベンゾチオフェン化合物、中間体、組成物および方法 |
US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/xx unknown
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Application Discontinuation
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/xx unknown
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/ko not_active Application Discontinuation
- 1998-04-07 CN CN98805957A patent/CN1259945A/zh active Pending
- 1998-04-07 PL PL98336206A patent/PL336206A1/xx unknown
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
- 1998-04-07 EA EA199900910A patent/EA199900910A1/ru unknown
- 1998-04-07 ID IDW991189A patent/ID23653A/id unknown
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 IL IL13227998A patent/IL132279A0/xx unknown
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/hu unknown
- 1998-04-07 JP JP54309098A patent/JP2001518897A/ja active Pending
-
1999
- 1999-10-08 NO NO994902A patent/NO994902L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0975628A4 (en) | 2001-03-21 |
EP0975628A1 (en) | 2000-02-02 |
WO1998045286A1 (en) | 1998-10-15 |
TR199903244T2 (xx) | 2000-05-22 |
CN1259945A (zh) | 2000-07-12 |
ID23653A (id) | 2000-05-11 |
HUP0001845A2 (hu) | 2001-06-28 |
NO994902L (no) | 1999-12-07 |
NO994902D0 (no) | 1999-10-08 |
KR20010006215A (ko) | 2001-01-26 |
AU6957398A (en) | 1998-10-30 |
CA2286207A1 (en) | 1998-10-15 |
EA199900910A1 (ru) | 2000-04-24 |
IL132279A0 (en) | 2001-03-19 |
JP2001518897A (ja) | 2001-10-16 |
PL336206A1 (en) | 2000-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200108846B (en) | Glucocorticoid receptor modulators. | |
HK1035671A1 (en) | Adenosine a3 receptor modulators. | |
EP0971588A4 (en) | NEW CANNABINOID RECEPTOR MODULATORS | |
AU4557099A (en) | Novel therapeutic agents that modulate estrogen receptors | |
ZA991301B (en) | Glutamate receptor modulators. | |
AU1199600A (en) | Estrogen receptor ligands | |
ZA966721B (en) | Bowl for hand mixing. | |
MXPA01011294A (es) | Compuestos moduladores de receptor de progesterona tetraciclicos y metodos. | |
GB9517098D0 (en) | Receptor | |
ZA982818B (en) | Prevention of breast cancer using selective estrogen receptor modulators. | |
EP1084142A4 (en) | GPR35A RECEIVER | |
GB9715815D0 (en) | Histamine H receptor ligands | |
ZA981338B (en) | Neurturin receptor. | |
GB9928566D0 (en) | Human vanilloid receptor-like receptor | |
GB9715816D0 (en) | Histamine H receptor ligands | |
GB9803062D0 (en) | Estrogen receptor ligands | |
GB9913649D0 (en) | Estrogen receptor | |
GB9722884D0 (en) | Estrogen receptor | |
GB9717346D0 (en) | Estrogen receptor ligands | |
GB9711992D0 (en) | Estrogen receptor ligands | |
GB9806032D0 (en) | Estrogen receptor | |
EP1109565A4 (en) | GABAB1AA RECEPTOR | |
GB9803202D0 (en) | Estrogen Receptor Ligands | |
GB9803061D0 (en) | Estrogen receptor ligands | |
GB9808613D0 (en) | Receptor system |